Catalyst Wire Dossier Catalyst Wire Dossier

Ixmyelocel-T (Formerly Vascular Repair Cells [VRC])

Ixmyelocel-T · Vericel Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ixmyelocel-T (Formerly Vascular Repair Cells [VRC]), covering 2020-05-20 to 2020-05-20. Get the full timeline:

Most recent: Clinical Trial Update: Use of Ixmyelocel-T (Formerly Vascular Repair Cells [VRC]) in Patients With Peripheral Arterial Disease to Treat Critical Limb Ischemia [Phase 2]

See pricing